Christopher Link
Concepts (396)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Caenorhabditis elegans | 47 | 2019 | 305 | 6.290 |
Why?
| | Amyloid beta-Peptides | 24 | 2021 | 220 | 4.400 |
Why?
| | Caenorhabditis elegans Proteins | 20 | 2019 | 198 | 3.160 |
Why?
| | Alzheimer Disease | 17 | 2023 | 558 | 2.010 |
Why?
| | Astrocytes | 3 | 2024 | 210 | 1.930 |
Why?
| | Peptide Fragments | 10 | 2021 | 705 | 1.600 |
Why?
| | RNA, Double-Stranded | 6 | 2023 | 57 | 1.410 |
Why?
| | Animals, Genetically Modified | 27 | 2018 | 239 | 1.340 |
Why?
| | Neurons | 10 | 2024 | 1587 | 1.290 |
Why?
| | Induced Pluripotent Stem Cells | 2 | 2024 | 247 | 1.170 |
Why?
| | DNA-Binding Proteins | 9 | 2023 | 1501 | 1.150 |
Why?
| | RNA-Binding Proteins | 4 | 2019 | 423 | 0.930 |
Why?
| | Cell Differentiation | 2 | 2024 | 1982 | 0.840 |
Why?
| | Coculture Techniques | 1 | 2024 | 239 | 0.840 |
Why?
| | RNA, Helminth | 5 | 2019 | 18 | 0.810 |
Why?
| | C9orf72 Protein | 5 | 2019 | 12 | 0.810 |
Why?
| | Heat-Shock Response | 2 | 2019 | 77 | 0.770 |
Why?
| | Amyotrophic Lateral Sclerosis | 7 | 2023 | 88 | 0.770 |
Why?
| | Animals | 64 | 2024 | 36847 | 0.680 |
Why?
| | Cell Nucleus | 3 | 2019 | 617 | 0.670 |
Why?
| | Aging | 10 | 2023 | 1864 | 0.650 |
Why?
| | Gene Knockdown Techniques | 3 | 2021 | 327 | 0.650 |
Why?
| | Heat-Shock Proteins | 7 | 2010 | 142 | 0.630 |
Why?
| | Green Fluorescent Proteins | 10 | 2019 | 390 | 0.620 |
Why?
| | Disease Models, Animal | 17 | 2019 | 4282 | 0.590 |
Why?
| | Chromosomal Proteins, Non-Histone | 2 | 2019 | 126 | 0.590 |
Why?
| | Neurodegenerative Diseases | 4 | 2022 | 135 | 0.570 |
Why?
| | Chromosomes, Human, Pair 21 | 1 | 2018 | 44 | 0.570 |
Why?
| | Transcriptome | 4 | 2021 | 969 | 0.560 |
Why?
| | Endosomes | 1 | 2018 | 136 | 0.550 |
Why?
| | Longevity | 7 | 2021 | 164 | 0.540 |
Why?
| | Trisomy | 1 | 2018 | 80 | 0.540 |
Why?
| | Brain | 9 | 2023 | 2664 | 0.530 |
Why?
| | Oxidative Stress | 12 | 2012 | 1314 | 0.510 |
Why?
| | Transcription, Genetic | 5 | 2019 | 1455 | 0.510 |
Why?
| | Proteins | 5 | 2021 | 1008 | 0.490 |
Why?
| | Receptor, Insulin | 3 | 2010 | 105 | 0.460 |
Why?
| | Genes, Helminth | 4 | 2018 | 26 | 0.440 |
Why?
| | Models, Animal | 2 | 2018 | 384 | 0.430 |
Why?
| | Paralysis | 3 | 2010 | 70 | 0.420 |
Why?
| | RNA Stability | 1 | 2014 | 117 | 0.420 |
Why?
| | Cytokines | 1 | 2021 | 2084 | 0.410 |
Why?
| | Immunity, Innate | 1 | 2019 | 825 | 0.410 |
Why?
| | Gene Expression | 6 | 2016 | 1500 | 0.400 |
Why?
| | Plant Extracts | 3 | 2010 | 202 | 0.400 |
Why?
| | Drosophila melanogaster | 4 | 2017 | 233 | 0.390 |
Why?
| | Cells, Cultured | 6 | 2024 | 4191 | 0.380 |
Why?
| | Gene Expression Profiling | 4 | 2021 | 1772 | 0.380 |
Why?
| | Molecular Chaperones | 2 | 2005 | 195 | 0.380 |
Why?
| | Gene Expression Regulation | 6 | 2016 | 2605 | 0.370 |
Why?
| | Luminescent Proteins | 5 | 2015 | 178 | 0.360 |
Why?
| | Down Syndrome | 1 | 2018 | 490 | 0.360 |
Why?
| | Autophagy | 2 | 2019 | 280 | 0.350 |
Why?
| | Transgenes | 6 | 2016 | 179 | 0.350 |
Why?
| | Peptides | 3 | 2019 | 980 | 0.340 |
Why?
| | Cell Death | 1 | 2012 | 372 | 0.330 |
Why?
| | Carrier Proteins | 2 | 2016 | 769 | 0.320 |
Why?
| | Prealbumin | 2 | 2016 | 29 | 0.310 |
Why?
| | RNA Interference | 7 | 2018 | 466 | 0.310 |
Why?
| | Sequence Analysis, RNA | 4 | 2021 | 452 | 0.290 |
Why?
| | Alternative Splicing | 4 | 2018 | 229 | 0.290 |
Why?
| | Heat-Shock Proteins, Small | 1 | 2007 | 2 | 0.290 |
Why?
| | Stress, Physiological | 5 | 2021 | 441 | 0.280 |
Why?
| | Tumor Necrosis Factor-alpha | 2 | 2021 | 1242 | 0.270 |
Why?
| | Computational Biology | 2 | 2021 | 643 | 0.270 |
Why?
| | Genes, Reporter | 3 | 2016 | 268 | 0.260 |
Why?
| | Hemolysin Proteins | 2 | 2018 | 34 | 0.260 |
Why?
| | Hydrogen Sulfide | 3 | 2021 | 44 | 0.260 |
Why?
| | Synapses | 1 | 2010 | 427 | 0.250 |
Why?
| | Endotoxins | 2 | 2018 | 220 | 0.250 |
Why?
| | Humans | 36 | 2024 | 136765 | 0.240 |
Why?
| | Frontal Lobe | 2 | 2017 | 149 | 0.240 |
Why?
| | Mutation | 10 | 2017 | 3946 | 0.230 |
Why?
| | Gene Deletion | 2 | 2018 | 389 | 0.230 |
Why?
| | Endoplasmic Reticulum | 2 | 2019 | 264 | 0.230 |
Why?
| | Basic Helix-Loop-Helix Transcription Factors | 2 | 2024 | 242 | 0.230 |
Why?
| | Rats | 5 | 2019 | 5639 | 0.220 |
Why?
| | eIF-2 Kinase | 1 | 2024 | 31 | 0.220 |
Why?
| | Oligonucleotide Array Sequence Analysis | 3 | 2003 | 766 | 0.220 |
Why?
| | Electrodes | 1 | 2024 | 111 | 0.220 |
Why?
| | Nerve Tissue Proteins | 2 | 2024 | 595 | 0.210 |
Why?
| | Organisms, Genetically Modified | 1 | 2003 | 15 | 0.210 |
Why?
| | Wakefulness | 1 | 2024 | 125 | 0.210 |
Why?
| | Primary Cell Culture | 2 | 2021 | 171 | 0.200 |
Why?
| | Blood-Brain Barrier | 1 | 2024 | 138 | 0.200 |
Why?
| | Mice, Knockout | 4 | 2024 | 3008 | 0.200 |
Why?
| | alpha-Crystallin B Chain | 1 | 2003 | 24 | 0.200 |
Why?
| | Brain Chemistry | 1 | 2003 | 116 | 0.200 |
Why?
| | Mice, Inbred C57BL | 6 | 2024 | 5749 | 0.190 |
Why?
| | Transfection | 4 | 2012 | 941 | 0.190 |
Why?
| | Sleep Deprivation | 1 | 2024 | 174 | 0.190 |
Why?
| | Protein Aggregation, Pathological | 2 | 2019 | 19 | 0.190 |
Why?
| | Cell Line | 4 | 2019 | 2838 | 0.190 |
Why?
| | Bacterial Proteins | 3 | 2018 | 873 | 0.190 |
Why?
| | Amino Acid Sequence | 5 | 2008 | 2138 | 0.190 |
Why?
| | Microscopy, Fluorescence | 4 | 2010 | 397 | 0.190 |
Why?
| | Regulatory Sequences, Nucleic Acid | 1 | 2002 | 91 | 0.190 |
Why?
| | Dipeptides | 2 | 2019 | 50 | 0.180 |
Why?
| | Complement C1q | 1 | 2021 | 37 | 0.180 |
Why?
| | Immunoblotting | 4 | 2019 | 306 | 0.180 |
Why?
| | Signal Transduction | 4 | 2016 | 5076 | 0.180 |
Why?
| | Amino Acids, Sulfur | 1 | 2021 | 7 | 0.180 |
Why?
| | Interleukin-1alpha | 1 | 2021 | 58 | 0.180 |
Why?
| | Cystathionine gamma-Lyase | 1 | 2021 | 13 | 0.180 |
Why?
| | Activating Transcription Factor 4 | 1 | 2021 | 20 | 0.180 |
Why?
| | Diet, High-Fat | 1 | 2022 | 247 | 0.180 |
Why?
| | Amyloidosis | 1 | 2001 | 42 | 0.170 |
Why?
| | DNA Repeat Expansion | 2 | 2017 | 10 | 0.170 |
Why?
| | Repetitive Sequences, Nucleic Acid | 2 | 2019 | 113 | 0.170 |
Why?
| | Helminth Proteins | 1 | 2000 | 24 | 0.170 |
Why?
| | Staining and Labeling | 1 | 2001 | 148 | 0.170 |
Why?
| | Hippocampus | 2 | 2018 | 894 | 0.170 |
Why?
| | Viruses | 1 | 2021 | 112 | 0.170 |
Why?
| | Mice | 14 | 2024 | 17757 | 0.160 |
Why?
| | Molecular Sequence Data | 5 | 2007 | 2894 | 0.160 |
Why?
| | Embryo, Mammalian | 2 | 2018 | 232 | 0.160 |
Why?
| | RNA | 2 | 2018 | 921 | 0.160 |
Why?
| | Frontotemporal Lobar Degeneration | 2 | 2017 | 18 | 0.160 |
Why?
| | Mitochondria | 3 | 2016 | 946 | 0.160 |
Why?
| | RNA, Small Interfering | 2 | 2019 | 622 | 0.160 |
Why?
| | Ultracentrifugation | 2 | 2017 | 52 | 0.160 |
Why?
| | Artificial Intelligence | 1 | 2022 | 275 | 0.150 |
Why?
| | Glutathione Reductase | 1 | 2019 | 25 | 0.150 |
Why?
| | Protein Aggregates | 2 | 2019 | 72 | 0.150 |
Why?
| | Recombinant Fusion Proteins | 4 | 2015 | 664 | 0.150 |
Why?
| | Frontotemporal Dementia | 2 | 2016 | 56 | 0.150 |
Why?
| | Proteostasis | 1 | 2019 | 29 | 0.150 |
Why?
| | Acrylates | 1 | 2018 | 47 | 0.150 |
Why?
| | Morpholinos | 1 | 2018 | 30 | 0.150 |
Why?
| | Protein-Tyrosine Kinases | 1 | 2002 | 434 | 0.150 |
Why?
| | Sphingomyelin Phosphodiesterase | 1 | 2018 | 26 | 0.150 |
Why?
| | Heterochromatin | 1 | 2019 | 53 | 0.150 |
Why?
| | Phosphatidylinositol 3-Kinases | 1 | 2000 | 366 | 0.150 |
Why?
| | RNA Editing | 1 | 2018 | 24 | 0.140 |
Why?
| | Protein Structure, Secondary | 1 | 2019 | 374 | 0.140 |
Why?
| | Vesicular Transport Proteins | 1 | 2018 | 84 | 0.140 |
Why?
| | Sleep | 1 | 2024 | 753 | 0.140 |
Why?
| | Blotting, Western | 5 | 2017 | 1225 | 0.140 |
Why?
| | Up-Regulation | 3 | 2009 | 844 | 0.140 |
Why?
| | Frailty | 1 | 2021 | 169 | 0.140 |
Why?
| | Huntingtin Protein | 1 | 2017 | 13 | 0.140 |
Why?
| | Inclusion Bodies | 3 | 2016 | 25 | 0.140 |
Why?
| | Cognitive Dysfunction | 1 | 2023 | 381 | 0.140 |
Why?
| | Behavior, Animal | 3 | 2016 | 497 | 0.140 |
Why?
| | Phenotype | 4 | 2019 | 3189 | 0.140 |
Why?
| | Autopsy | 1 | 2017 | 93 | 0.140 |
Why?
| | Cytoplasmic Granules | 1 | 2018 | 93 | 0.140 |
Why?
| | Glutathione | 1 | 2019 | 356 | 0.130 |
Why?
| | Animals, Newborn | 1 | 2019 | 844 | 0.130 |
Why?
| | Saccharomyces cerevisiae | 2 | 2019 | 556 | 0.130 |
Why?
| | Heterozygote | 1 | 2017 | 293 | 0.130 |
Why?
| | Inflammation Mediators | 1 | 2019 | 513 | 0.130 |
Why?
| | MAP Kinase Kinase Kinases | 1 | 2016 | 73 | 0.120 |
Why?
| | Wound Healing | 1 | 2018 | 328 | 0.120 |
Why?
| | Cell Survival | 1 | 2019 | 1116 | 0.120 |
Why?
| | Phosphorylation | 2 | 2018 | 1758 | 0.120 |
Why?
| | Guanine Nucleotide Exchange Factors | 1 | 2016 | 66 | 0.120 |
Why?
| | Intestines | 1 | 2018 | 357 | 0.120 |
Why?
| | Transcriptional Activation | 1 | 2017 | 378 | 0.120 |
Why?
| | Enzyme Inhibitors | 1 | 2018 | 839 | 0.120 |
Why?
| | tau Proteins | 2 | 2006 | 88 | 0.120 |
Why?
| | Mitogen-Activated Protein Kinases | 1 | 2016 | 313 | 0.110 |
Why?
| | Diet | 2 | 2021 | 1274 | 0.110 |
Why?
| | Conserved Sequence | 2 | 2007 | 239 | 0.110 |
Why?
| | Chromatin | 1 | 2018 | 519 | 0.110 |
Why?
| | RNA Polymerase II | 1 | 2017 | 324 | 0.110 |
Why?
| | Protein Processing, Post-Translational | 1 | 2016 | 465 | 0.110 |
Why?
| | Proteasome Endopeptidase Complex | 1 | 2014 | 155 | 0.110 |
Why?
| | Neuroprotective Agents | 2 | 2012 | 131 | 0.110 |
Why?
| | Transcription Factors | 4 | 2011 | 1718 | 0.100 |
Why?
| | Cerebellum | 1 | 2015 | 224 | 0.100 |
Why?
| | Adaptor Proteins, Signal Transducing | 2 | 2009 | 428 | 0.100 |
Why?
| | Glutathione Transferase | 2 | 2003 | 105 | 0.100 |
Why?
| | Repressor Proteins | 1 | 2016 | 427 | 0.100 |
Why?
| | Microscopy, Confocal | 2 | 2012 | 324 | 0.100 |
Why?
| | Cricetulus | 2 | 2012 | 109 | 0.100 |
Why?
| | Gastrointestinal Microbiome | 1 | 2020 | 697 | 0.100 |
Why?
| | Shab Potassium Channels | 1 | 2012 | 18 | 0.100 |
Why?
| | Neurites | 1 | 2012 | 48 | 0.100 |
Why?
| | Adaptor Proteins, Vesicular Transport | 1 | 2012 | 45 | 0.100 |
Why?
| | Cricetinae | 2 | 2012 | 289 | 0.100 |
Why?
| | Caloric Restriction | 2 | 2010 | 123 | 0.090 |
Why?
| | Molecular Targeted Therapy | 1 | 2014 | 411 | 0.090 |
Why?
| | Sequence Analysis, Protein | 2 | 2008 | 30 | 0.090 |
Why?
| | Promoter Regions, Genetic | 3 | 2010 | 1249 | 0.090 |
Why?
| | Immunohistochemistry | 4 | 2012 | 1733 | 0.090 |
Why?
| | Male | 12 | 2024 | 67311 | 0.090 |
Why?
| | Intercellular Signaling Peptides and Proteins | 1 | 2012 | 382 | 0.080 |
Why?
| | Protein Structure, Quaternary | 1 | 2010 | 125 | 0.080 |
Why?
| | Base Sequence | 2 | 2005 | 2179 | 0.080 |
Why?
| | Presenilin-1 | 2 | 2012 | 31 | 0.080 |
Why?
| | Caffeine | 1 | 2010 | 68 | 0.080 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 2 | 2012 | 851 | 0.080 |
Why?
| | Amyloid beta-Protein Precursor | 2 | 2012 | 66 | 0.080 |
Why?
| | Fertility | 1 | 2011 | 160 | 0.080 |
Why?
| | Fasting | 2 | 2022 | 280 | 0.080 |
Why?
| | Renin | 2 | 2007 | 35 | 0.080 |
Why?
| | NADPH Oxidases | 2 | 2007 | 113 | 0.080 |
Why?
| | HSP70 Heat-Shock Proteins | 2 | 2017 | 73 | 0.080 |
Why?
| | Sequence Deletion | 1 | 2010 | 183 | 0.080 |
Why?
| | Case-Control Studies | 1 | 2017 | 3539 | 0.080 |
Why?
| | Mutagenesis, Site-Directed | 2 | 2002 | 374 | 0.080 |
Why?
| | Prenylation | 1 | 2009 | 3 | 0.080 |
Why?
| | Neuropeptides | 1 | 2009 | 73 | 0.080 |
Why?
| | Protein Structure, Tertiary | 2 | 2009 | 860 | 0.080 |
Why?
| | Renin-Angiotensin System | 2 | 2007 | 84 | 0.080 |
Why?
| | RNA, Messenger | 5 | 2018 | 2831 | 0.080 |
Why?
| | Biotinylation | 1 | 2008 | 32 | 0.070 |
Why?
| | Genitalia, Male | 1 | 1988 | 11 | 0.070 |
Why?
| | Endocytosis | 1 | 2009 | 169 | 0.070 |
Why?
| | Antioxidants | 2 | 2021 | 584 | 0.070 |
Why?
| | Proteomics | 2 | 2005 | 1109 | 0.070 |
Why?
| | CHO Cells | 1 | 2008 | 161 | 0.070 |
Why?
| | Movement | 1 | 2010 | 272 | 0.070 |
Why?
| | Muscle, Skeletal | 2 | 2009 | 1710 | 0.070 |
Why?
| | Antigens, Surface | 1 | 1988 | 153 | 0.070 |
Why?
| | Survival Rate | 2 | 2010 | 1963 | 0.070 |
Why?
| | Fluorescent Antibody Technique | 1 | 2008 | 388 | 0.070 |
Why?
| | Amino Acid Substitution | 1 | 2008 | 306 | 0.070 |
Why?
| | Oxidation-Reduction | 4 | 2019 | 1059 | 0.070 |
Why?
| | Ginkgolides | 1 | 2006 | 4 | 0.070 |
Why?
| | Spironolactone | 1 | 2007 | 36 | 0.070 |
Why?
| | Lysosomes | 1 | 2007 | 141 | 0.070 |
Why?
| | Mineralocorticoid Receptor Antagonists | 1 | 2007 | 54 | 0.070 |
Why?
| | Hypertension, Renal | 1 | 2006 | 16 | 0.060 |
Why?
| | Electrophoresis, Gel, Two-Dimensional | 3 | 2017 | 114 | 0.060 |
Why?
| | Protein Biosynthesis | 2 | 2021 | 430 | 0.060 |
Why?
| | Cardiomegaly | 1 | 2007 | 175 | 0.060 |
Why?
| | Isoflavones | 1 | 2005 | 26 | 0.060 |
Why?
| | Regulatory Factor X Transcription Factors | 1 | 2005 | 11 | 0.060 |
Why?
| | Dementia | 1 | 2009 | 256 | 0.060 |
Why?
| | Solubility | 1 | 2005 | 245 | 0.060 |
Why?
| | Phytotherapy | 1 | 2005 | 83 | 0.060 |
Why?
| | Ventricular Remodeling | 1 | 2007 | 262 | 0.060 |
Why?
| | Feeding Behavior | 1 | 2010 | 648 | 0.060 |
Why?
| | DNA | 2 | 2021 | 1458 | 0.060 |
Why?
| | DNA Primers | 1 | 2005 | 514 | 0.060 |
Why?
| | Cell Proliferation | 1 | 2012 | 2475 | 0.060 |
Why?
| | Cloning, Molecular | 1 | 2005 | 534 | 0.060 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2007 | 455 | 0.060 |
Why?
| | Aged | 3 | 2017 | 23794 | 0.060 |
Why?
| | Sleep, REM | 1 | 2024 | 33 | 0.060 |
Why?
| | Genetic Vectors | 1 | 2005 | 317 | 0.050 |
Why?
| | Protein Binding | 2 | 2002 | 2216 | 0.050 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 2 | 2003 | 975 | 0.050 |
Why?
| | Genome | 2 | 2003 | 294 | 0.050 |
Why?
| | Models, Genetic | 1 | 2006 | 599 | 0.050 |
Why?
| | Neurofibrils | 1 | 2003 | 1 | 0.050 |
Why?
| | Body Temperature | 1 | 2024 | 221 | 0.050 |
Why?
| | Plaque, Amyloid | 1 | 2003 | 15 | 0.050 |
Why?
| | Gliosis | 1 | 2023 | 28 | 0.050 |
Why?
| | Saccharomyces cerevisiae Proteins | 2 | 2018 | 404 | 0.050 |
Why?
| | Onchocerca volvulus | 1 | 2003 | 1 | 0.050 |
Why?
| | Reverse Transcriptase Inhibitors | 1 | 2023 | 84 | 0.050 |
Why?
| | Operon | 1 | 2002 | 64 | 0.050 |
Why?
| | Models, Biological | 2 | 2007 | 1773 | 0.050 |
Why?
| | Cell Line, Tumor | 1 | 2010 | 3405 | 0.050 |
Why?
| | Liver | 2 | 2021 | 1940 | 0.050 |
Why?
| | Hyperbaric Oxygenation | 1 | 2002 | 39 | 0.050 |
Why?
| | Prion Diseases | 1 | 2001 | 15 | 0.050 |
Why?
| | Multigene Family | 1 | 2002 | 198 | 0.050 |
Why?
| | Electroencephalography | 1 | 2024 | 430 | 0.050 |
Why?
| | Probability | 1 | 2002 | 304 | 0.040 |
Why?
| | Microscopy, Immunoelectron | 1 | 2001 | 44 | 0.040 |
Why?
| | Alkenes | 1 | 2001 | 9 | 0.040 |
Why?
| | Statistics, Nonparametric | 1 | 2002 | 431 | 0.040 |
Why?
| | Benzoates | 1 | 2001 | 43 | 0.040 |
Why?
| | Diet Therapy | 1 | 2021 | 37 | 0.040 |
Why?
| | Motor Neurons | 1 | 2023 | 234 | 0.040 |
Why?
| | Species Specificity | 1 | 2002 | 586 | 0.040 |
Why?
| | Hydrogen | 1 | 2021 | 70 | 0.040 |
Why?
| | Lipopolysaccharides | 1 | 2024 | 886 | 0.040 |
Why?
| | Down-Regulation | 1 | 2003 | 656 | 0.040 |
Why?
| | Spinal Cord | 1 | 2023 | 370 | 0.040 |
Why?
| | Methylamines | 1 | 2020 | 34 | 0.040 |
Why?
| | Female | 5 | 2021 | 72795 | 0.040 |
Why?
| | Nematoda | 1 | 1999 | 9 | 0.040 |
Why?
| | Muscles | 1 | 2021 | 325 | 0.040 |
Why?
| | Fibroblast Growth Factors | 1 | 2021 | 171 | 0.040 |
Why?
| | Insulin | 1 | 2010 | 2406 | 0.040 |
Why?
| | Maleates | 1 | 2019 | 4 | 0.040 |
Why?
| | Nuclear Lamina | 1 | 2019 | 10 | 0.040 |
Why?
| | Sequestosome-1 Protein | 1 | 2019 | 14 | 0.040 |
Why?
| | Fluorescent Dyes | 1 | 2001 | 317 | 0.040 |
Why?
| | alpha-Synuclein | 1 | 2019 | 34 | 0.040 |
Why?
| | Recombinant Proteins | 1 | 2002 | 1350 | 0.040 |
Why?
| | Muscle Cells | 1 | 2019 | 43 | 0.040 |
Why?
| | Reproduction | 2 | 2011 | 204 | 0.040 |
Why?
| | Binding Sites | 1 | 2002 | 1301 | 0.040 |
Why?
| | Middle Aged | 2 | 2017 | 33228 | 0.040 |
Why?
| | Membrane Proteins | 1 | 2005 | 1163 | 0.040 |
Why?
| | Dimerization | 1 | 1998 | 198 | 0.040 |
Why?
| | Proteolysis | 1 | 2019 | 177 | 0.040 |
Why?
| | Oxidants | 2 | 2012 | 111 | 0.040 |
Why?
| | Body Composition | 1 | 2021 | 679 | 0.030 |
Why?
| | Genetic Variation | 1 | 2002 | 985 | 0.030 |
Why?
| | Antibodies | 1 | 2019 | 411 | 0.030 |
Why?
| | Genomics | 1 | 2002 | 790 | 0.030 |
Why?
| | Ribonucleoproteins | 1 | 2018 | 105 | 0.030 |
Why?
| | Hydrogen Peroxide | 2 | 2012 | 327 | 0.030 |
Why?
| | Electron Transport Chain Complex Proteins | 1 | 2016 | 20 | 0.030 |
Why?
| | Larva | 1 | 2017 | 224 | 0.030 |
Why?
| | Microscopy, Electron, Transmission | 2 | 2007 | 150 | 0.030 |
Why?
| | Ubiquitinated Proteins | 1 | 2016 | 2 | 0.030 |
Why?
| | Transcriptional Elongation Factors | 1 | 2016 | 40 | 0.030 |
Why?
| | HEK293 Cells | 1 | 2019 | 729 | 0.030 |
Why?
| | Unfolded Protein Response | 1 | 2016 | 59 | 0.030 |
Why?
| | Electron Transport | 1 | 2016 | 115 | 0.030 |
Why?
| | Nerve Degeneration | 1 | 2016 | 46 | 0.030 |
Why?
| | Analysis of Variance | 2 | 2012 | 1316 | 0.030 |
Why?
| | Heterogeneous-Nuclear Ribonucleoprotein Group F-H | 1 | 2015 | 1 | 0.030 |
Why?
| | Parkinson Disease | 1 | 2001 | 490 | 0.030 |
Why?
| | Mass Spectrometry | 2 | 2012 | 738 | 0.030 |
Why?
| | Ginkgo biloba | 2 | 2006 | 8 | 0.030 |
Why?
| | Atrophy | 1 | 2016 | 184 | 0.030 |
Why?
| | Drosophila Proteins | 1 | 2017 | 205 | 0.030 |
Why?
| | Fluorescence | 1 | 2015 | 160 | 0.030 |
Why?
| | p38 Mitogen-Activated Protein Kinases | 1 | 2016 | 283 | 0.030 |
Why?
| | Spectrometry, Fluorescence | 1 | 2015 | 168 | 0.030 |
Why?
| | Homeostasis | 1 | 2019 | 619 | 0.030 |
Why?
| | Sex Factors | 1 | 2021 | 2060 | 0.030 |
Why?
| | Polyadenylation | 1 | 2015 | 42 | 0.030 |
Why?
| | Protein Conformation | 1 | 2017 | 933 | 0.030 |
Why?
| | Genetic Association Studies | 1 | 2015 | 375 | 0.030 |
Why?
| | Kidney | 1 | 2021 | 1467 | 0.030 |
Why?
| | Clioquinol | 1 | 2012 | 7 | 0.030 |
Why?
| | Cognition | 1 | 2020 | 1146 | 0.020 |
Why?
| | Propanols | 1 | 2012 | 1 | 0.020 |
Why?
| | Gene Expression Regulation, Developmental | 1 | 2017 | 858 | 0.020 |
Why?
| | 2,2'-Dipyridyl | 1 | 2012 | 6 | 0.020 |
Why?
| | Fluoresceins | 1 | 2012 | 47 | 0.020 |
Why?
| | Organ Culture Techniques | 1 | 2012 | 156 | 0.020 |
Why?
| | Drug Evaluation, Preclinical | 1 | 2012 | 184 | 0.020 |
Why?
| | Disulfides | 1 | 2012 | 107 | 0.020 |
Why?
| | Apoptosis | 2 | 2012 | 2551 | 0.020 |
Why?
| | Gonads | 1 | 2011 | 23 | 0.020 |
Why?
| | Models, Molecular | 1 | 2016 | 1570 | 0.020 |
Why?
| | Nuclear Proteins | 1 | 2016 | 712 | 0.020 |
Why?
| | Alanine | 1 | 2012 | 152 | 0.020 |
Why?
| | Membrane Potentials | 1 | 2012 | 284 | 0.020 |
Why?
| | Electric Stimulation | 1 | 2012 | 264 | 0.020 |
Why?
| | Patch-Clamp Techniques | 1 | 2012 | 286 | 0.020 |
Why?
| | Rats, Sprague-Dawley | 2 | 2007 | 2486 | 0.020 |
Why?
| | Aged, 80 and over | 1 | 2003 | 7585 | 0.020 |
Why?
| | Germ Cells | 1 | 2011 | 63 | 0.020 |
Why?
| | Cysteine | 1 | 2012 | 204 | 0.020 |
Why?
| | Quality of Life | 1 | 2022 | 2878 | 0.020 |
Why?
| | Microarray Analysis | 1 | 2010 | 116 | 0.020 |
Why?
| | Forkhead Transcription Factors | 1 | 2010 | 190 | 0.020 |
Why?
| | Blood Pressure | 2 | 2007 | 1774 | 0.020 |
Why?
| | Association Learning | 1 | 2010 | 60 | 0.020 |
Why?
| | Central Nervous System Depressants | 1 | 2010 | 85 | 0.020 |
Why?
| | Odorants | 1 | 2010 | 109 | 0.020 |
Why?
| | Obesity | 1 | 2022 | 2982 | 0.020 |
Why?
| | Ribosomes | 1 | 2010 | 186 | 0.020 |
Why?
| | Ubiquitin | 1 | 2009 | 66 | 0.020 |
Why?
| | Caenorhabditis | 1 | 1988 | 3 | 0.020 |
Why?
| | Microscopy, Interference | 1 | 1988 | 9 | 0.020 |
Why?
| | Sex Determination Analysis | 1 | 1988 | 6 | 0.020 |
Why?
| | Caspases | 1 | 2009 | 247 | 0.020 |
Why?
| | Hot Temperature | 1 | 2010 | 391 | 0.020 |
Why?
| | Receptors, Mineralocorticoid | 1 | 2007 | 10 | 0.020 |
Why?
| | Serotonin | 1 | 2010 | 323 | 0.020 |
Why?
| | Paresis | 1 | 2006 | 30 | 0.020 |
Why?
| | Malondialdehyde | 1 | 2006 | 29 | 0.020 |
Why?
| | Valsartan | 1 | 2006 | 29 | 0.020 |
Why?
| | Peptidyl-Dipeptidase A | 1 | 2006 | 52 | 0.020 |
Why?
| | Tetrazoles | 1 | 2006 | 40 | 0.020 |
Why?
| | Angiotensin II Type 1 Receptor Blockers | 1 | 2006 | 38 | 0.020 |
Why?
| | Chemotaxis | 1 | 2006 | 130 | 0.020 |
Why?
| | Neprilysin | 1 | 2006 | 47 | 0.020 |
Why?
| | Valine | 1 | 2006 | 82 | 0.020 |
Why?
| | Kidney Glomerulus | 1 | 2006 | 114 | 0.020 |
Why?
| | Podocytes | 1 | 2006 | 63 | 0.020 |
Why?
| | Dynamins | 1 | 2005 | 37 | 0.010 |
Why?
| | Albuminuria | 1 | 2006 | 185 | 0.010 |
Why?
| | Immunoprecipitation | 1 | 2005 | 155 | 0.010 |
Why?
| | Ethanol | 1 | 2010 | 606 | 0.010 |
Why?
| | Crystallins | 1 | 2005 | 59 | 0.010 |
Why?
| | Motor Activity | 1 | 2010 | 717 | 0.010 |
Why?
| | Age Factors | 1 | 2012 | 3284 | 0.010 |
Why?
| | Fibrosis | 1 | 2007 | 551 | 0.010 |
Why?
| | Naphthoquinones | 1 | 2003 | 19 | 0.010 |
Why?
| | Ventricular Dysfunction, Left | 1 | 2007 | 382 | 0.010 |
Why?
| | Protein O-Methyltransferase | 1 | 2003 | 1 | 0.010 |
Why?
| | Myocytes, Cardiac | 1 | 2007 | 523 | 0.010 |
Why?
| | Drug Resistance | 1 | 2003 | 169 | 0.010 |
Why?
| | RNA, Spliced Leader | 1 | 2002 | 12 | 0.010 |
Why?
| | Trans-Splicing | 1 | 2002 | 12 | 0.010 |
Why?
| | Gene Silencing | 1 | 2003 | 195 | 0.010 |
Why?
| | Myocardium | 1 | 2007 | 1001 | 0.010 |
Why?
| | Chronic Disease | 1 | 2007 | 1785 | 0.010 |
Why?
| | Pilot Projects | 1 | 2005 | 1692 | 0.010 |
Why?
| | Reactive Oxygen Species | 1 | 2003 | 621 | 0.010 |
Why?
| | Magnetic Resonance Imaging | 1 | 2007 | 3555 | 0.010 |
Why?
| | Adult | 1 | 2015 | 37631 | 0.010 |
Why?
|
|
Link's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|